EMMS

Dynamic Digital Transformation, a DMI Joint Venture, Wins $14.5 Million Contract with U.S. Treasury for Enterprise Mobility Management

Retrieved on: 
Thursday, March 21, 2024
Mobile, Wireless, Technology, Finance, Security, Banking, Telecommunications, Professional Services, Software, Internet, Data Management, Partnership, Comptroller, DDT, DMI, OCC, EMMS, Managed Mobility Services, Public sector, Government, EMM, Magic, Bank

DMI, a global leader in end-to-end managed mobility services, has partnered with Dynamic Solutions Technology to form a joint venture, Dynamic Digital Transformation (DDT), which has been awarded a contract by the U.S. Department of Treasury’s Office of the Comptroller of the Currency (OCC) to support and manage the bureau’s enterprise mobility management services (EMMS).

Key Points: 
  • DMI, a global leader in end-to-end managed mobility services, has partnered with Dynamic Solutions Technology to form a joint venture, Dynamic Digital Transformation (DDT), which has been awarded a contract by the U.S. Department of Treasury’s Office of the Comptroller of the Currency (OCC) to support and manage the bureau’s enterprise mobility management services (EMMS).
  • DMI will also deliver reporting and dashboarding capabilities that will increase visibility, tracking and transparency to reduce costs, improve productivity and increase security for the bureau.
  • We are proud to apply our expertise being at the crossroads of the public and private sectors to continue being a valued partner to the OCC,” said Amy Rall, president of DMI's federal group.
  • At the forefront of supporting mobile devices, DMI has delivered hundreds of successful implementations with a footprint in over 78 countries and more than four million mobile devices under management.

Emmis Announces $0.50 per Share Dividend and Annual Meeting of Shareholders

Retrieved on: 
Monday, July 31, 2023
Common stock, Ernst & Young, LLP, EMMS, OTC Markets Group, Common, OTC, Security (finance), Emmis Communications

INDIANAPOLIS, July 31, 2023 /PRNewswire/ -- Emmis Corporation (OTC: EMMS) ("Emmis") announced today that its board of directors has declared a special dividend of $0.50 per share of common stock, payable on September 22, 2023, to holders of record as of September 13, 2023.

Key Points: 
  • INDIANAPOLIS, July 31, 2023 /PRNewswire/ -- Emmis Corporation (OTC: EMMS) ("Emmis") announced today that its board of directors has declared a special dividend of $0.50 per share of common stock, payable on September 22, 2023, to holders of record as of September 13, 2023.
  • Additionally, Emmis announced that its annual meeting of shareholders will be held at 10:00 a.m. (Eastern) on August 29, 2023, at Emmis' headquarters building at 40 Monument Circle, Indianapolis, IN 46204.
  • Emmis has two classes of Common Stock, with the Class A Common Stock traded on the OTC Market and the Class B Common Stock solely owned by Emmis' Chairman, CEO and Founder, Jeffrey H. Smulyan.
  • Additional information will be available to Emmis shareholders through a proxy statement for the annual meeting.

CBT Partners with Telepresenz to Expand Connected Worker Capabilities

Retrieved on: 
Thursday, September 1, 2022
Knowledge, Partnership, CA, Workforce, Asset, CEO, Safety, PTC, Intel, ERP, CBT, Hewlett Packard Enterprise, Solution, IOT, LinkedIn, AIMS, OT, ABB, Blog, Orange, California, Software as a service, GLOBE, Connected, Internet of things, Video, Twitter, AMD, Condition monitoring, CTO, EMMS, Efficiency, Risk management, Cryptocurrency, NVIDIA

Together, CBT and Telepresenz will offer Connected Worker solutions including Remote Mentoring, Digital Workflow, and Knowledge Capture.

Key Points: 
  • Together, CBT and Telepresenz will offer Connected Worker solutions including Remote Mentoring, Digital Workflow, and Knowledge Capture.
  • The Connected Worker solutions will not only increase efficiency but also allow in-field data reporting, improved training, enhanced safety, and much more.
  • These capabilities bolster CBTs industry-leading portfolio of IoT and IT/OT convergence solutions, including Connected Worker, Worker Health & Safety, Condition Monitoring & Predictive Maintenance, Asset Integrity Management, and Video as a Sensor.
  • Were excited to partner with Telepresenz to further our Connected Worker capabilities.

Emmis Communications Corporation Confirms Commencement of Tender Offer to Repurchase up to One Million Class A Common Shares at Prices Not Greater Than $3.75 nor Less Than $2.75 per share

Retrieved on: 
Monday, July 11, 2022
Solution, Money transmitter, News, Public company, Risk, Personal Information Agent, EMMS, Hand, LLC, Company, OTC, Letter of transmittal, SEC, OTC Markets Group, Board, Letter, Organization, Board of directors, Security (finance), Emmis Communications

The tender offer is scheduled to expire, unless extended by the Company, at 5:00 P.M., New York City Time, on Friday, August 5, 2022.

Key Points: 
  • The tender offer is scheduled to expire, unless extended by the Company, at 5:00 P.M., New York City Time, on Friday, August 5, 2022.
  • The Company will fund the purchase of tendered shares primarily from cash on hand and borrowings under an existing $1.6 million line of credit.
  • Class A shares acquired in the tender offer will be acquired at the purchase price at which they were tendered.
  • Assuming one million Class A common shares are tendered, Emmis would repurchase approximately 11.0% of the Class A shares issued and outstanding as of July 1, 2022, and approximately 9.3% of Emmis' total common stock, which includes Class B common stock not subject to the tender offer.

Emmis Communications Announces Final Results of Tender Offer

Retrieved on: 
Monday, November 22, 2021
Personal Information Agent, News, OTC Markets Group, Risk, LLC, Solution, EMMS, OTC, Security (finance)

INDIANAPOLIS, Nov. 22, 2021 /PRNewswire/ -- Emmis Communications Corporation (OTC: EMMS) ("Emmis" or the "Company") announced today the final results of its cash tender offer to purchase up to 2 million shares of its Class A common stock at a purchase price of $2.60 per share.

Key Points: 
  • INDIANAPOLIS, Nov. 22, 2021 /PRNewswire/ -- Emmis Communications Corporation (OTC: EMMS) ("Emmis" or the "Company") announced today the final results of its cash tender offer to purchase up to 2 million shares of its Class A common stock at a purchase price of $2.60 per share.
  • Based on the final count by Broadridge, Inc., the Depositary for the tender offer, a total of 1,027,494 shares of Emmis' Class A common stock were properly tendered and not withdrawn.
  • In accordance with the terms and conditions of the tender offer, Emmis will purchase all of the shares tendered for an aggregate price of approximately $2.7 million, excluding fees and expenses relating to the tender offer.
  • Shareholders who have questions or would like additional information about the tender offer may contact the Information Agent for the tender offer, Alliance Advisors, LLC, toll-free at (855) 325-6673.

Emmis Communications Corporation Confirms Commencement of Tender Offer to Repurchase up to Two Million Class A Common Shares at $2.60 per share

Retrieved on: 
Thursday, October 28, 2021
Personal Information Agent, EMMS, Letter, Hand, Public company, SEC Rule 10b-5, SEC, Class, LLC, Company, Risk, OTC Markets Group, Board, OTC, News, Solution, Bloomberg, Letter of transmittal, Transmitter, Board of directors, Security (finance)

INDIANAPOLIS, Oct. 28, 2021 /PRNewswire/ -- Emmis Communications Corporation (OTC: EMMS) ("Emmis" or the "Company") confirmed today it commenced on October 21 2021, a tender offer to repurchase up to two million shares of its Class A common stock, at a price of $2.60 per share.

Key Points: 
  • INDIANAPOLIS, Oct. 28, 2021 /PRNewswire/ -- Emmis Communications Corporation (OTC: EMMS) ("Emmis" or the "Company") confirmed today it commenced on October 21 2021, a tender offer to repurchase up to two million shares of its Class A common stock, at a price of $2.60 per share.
  • The tender offer is scheduled to expire, unless extended by the Company, at 5:00 P.M., New York City Time, on Friday, November 19, 2021.
  • Assuming two million shares of Class A common stock are tendered, Emmis would repurchase approximately 16.5% of the shares of Class A common stock issued and outstanding as of October 21, 2021, and approximately 14.7% of our total common stock, which include shares of Class B common stock not subject to the tender offer.
  • This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any shares of Class A common stock.

MANTA Listed As Innovator In The Enterprise Metadata Management Software On 360Quadrants

Retrieved on: 
Wednesday, October 20, 2021
SWOT, Leadership, MANTA, EMMS, Metadata, Organization, USD, Software, Industry, DataOps, Risk management, Online shopping

360Quadrants has chosen a few of the Best Enterprise Metadata Management Software providers in the market.

Key Points: 
  • 360Quadrants has chosen a few of the Best Enterprise Metadata Management Software providers in the market.
  • This assessment assists buyers in knowing more about enterprise metadata management software and make the right decision based on their requirements.
  • MANTA is listed as an Innovator in the Enterprise Metadata Management Software (EMMS) segment on 360Quadrants.
  • This study also helps the analysts compute the overall score based on which enterprise metadata management software providers were ranked and positioned on 360Quadrants.

MANTA Listed As Innovator In The Enterprise Metadata Management Software On 360Quadrants

Retrieved on: 
Wednesday, October 20, 2021
SWOT, Leadership, MANTA, EMMS, Metadata, Organization, USD, Software, Industry, DataOps, Risk management, Online shopping

360Quadrants has chosen a few of the Best Enterprise Metadata Management Software providers in the market.

Key Points: 
  • 360Quadrants has chosen a few of the Best Enterprise Metadata Management Software providers in the market.
  • This assessment assists buyers in knowing more about enterprise metadata management software and make the right decision based on their requirements.
  • MANTA is listed as an Innovator in the Enterprise Metadata Management Software (EMMS) segment on 360Quadrants.
  • This study also helps the analysts compute the overall score based on which enterprise metadata management software providers were ranked and positioned on 360Quadrants.

New Publication Highlights Therapeutic Potential of Endogenous Metabolic Modulators (EMMs)

Retrieved on: 
Wednesday, September 30, 2020
Health, Clinical trials, Research, Pharmaceutical, Science, Biotechnology, Branches of biology, Signal transduction, Biology, Articles, Metabolism, Underwater diving physiology, MTOR, EMMS, Disease, Endogenous Metabolic Modulators (EMMs), Axcella’s Clinical Approach, Axcella

Entitled Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids, the new publication reviews literature on the use of this EMM class to treat diseases, with a focus on single and combination agents targeted to a single biology.

Key Points: 
  • Entitled Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids, the new publication reviews literature on the use of this EMM class to treat diseases, with a focus on single and combination agents targeted to a single biology.
  • It also describes how, utilizing a rational design approach, compositions of EMMs provide the potential for compounding multifactorial effects on a range of complex diseases.
  • Complex diseases, which tend to involve the dysregulation of a variety of underlying pathways and biologies, also are discussed in the publication.
  • Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions.

Company Profile for Axcella Health Inc.

Retrieved on: 
Thursday, September 24, 2020
Health, Biotechnology, Medical specialties, Clinical medicine, Hepatitis, RTT, Hepatology, Steatohepatitis, Non-alcoholic fatty liver disease, Hepatic encephalopathy, Nash, EMMS, EMMS

Axcella (Nasdaq: AXLA) is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health.

Key Points: 
  • Axcella (Nasdaq: AXLA) is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health.
  • The companys product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways.
  • Axcellas pipeline includes lead therapeutic candidates for non-alcoholic steatohepatitis (NASH) and the reduction in risk of overt hepatic encephalopathy (OHE) recurrence.
  • Additional muscle- and blood-related programs are in earlier-stage development.